QURE - uniQure wins FDA nod to study gene therapy for Fabry disease
2023-11-29 07:40:38 ET
More on uniQure
- uniQure: AMT-130 Data And Other Catalysts In H2 2023
- uniQure to cut over 50% of research projects in strategic review
- uniQure cleared to start U.S. trial for gene therapy
- Seeking Alpha’s Quant Rating on uniQure
- Historical earnings data for uniQure
For further details see:
uniQure wins FDA nod to study gene therapy for Fabry disease